Rayonier Advanced Set to Announce Q4 Earnings on March 3rd
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 10 hours ago
0mins
Should l Buy RYAM?
Source: seekingalpha
- Earnings Announcement: Rayonier Advanced (RYAM) is set to release its Q4 2023 earnings report on March 3rd after market close, with a consensus EPS estimate of -$0.08, reflecting a significant 68% year-over-year decline.
- Revenue Expectations: Analysts project revenue for the quarter to be $364.07 million, representing a 13.7% year-over-year decrease, indicating challenges the company faces in the current economic climate.
- Historical Performance Review: Over the past two years, RYAM has only beaten EPS estimates 25% of the time and revenue estimates 50% of the time, highlighting considerable volatility in its performance and the need for cautious investor assessment.
- Management Changes: Rayonier Advanced recently appointed Scott Sutton as CEO, a move that may influence the company's strategic direction and future performance outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RYAM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RYAM
Wall Street analysts forecast RYAM stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 9.470
Low
9.00
Averages
9.00
High
9.00
Current: 9.470
Low
9.00
Averages
9.00
High
9.00
About RYAM
Rayonier Advanced Materials Inc. specializes in cellulose-based technologies, including cellulose specialties, a natural polymer commonly used in the production of filters, food, pharmaceuticals and other industrial applications. The Company's segments include Cellulose Specialties, Cellulose Commodities, Biomaterials, Paperboard and High-Yield Pulp. The Company's specialized assets, capable of creating cellulose specialties products, are also used to produce commodity fluff pulp, biofuels, bioelectricity and other biomaterials such as bioethanol and tall oils. Its commodity fluff is typically used in consumer products such as baby diapers. Its tall oil soap is used as feedstock for producing crude tall oil. It manufactures products for the paper and packaging markets. It is a multi-ply paperboard producer in North America. It produces its high-yield pulp primarily from hardwood aspen, maple and birch species. It has manufacturing operations in the United States, Canada and France.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement: Rayonier Advanced (RYAM) is set to release its Q4 2023 earnings report on March 3rd after market close, with a consensus EPS estimate of -$0.08, reflecting a significant 68% year-over-year decline.
- Revenue Expectations: Analysts project revenue for the quarter to be $364.07 million, representing a 13.7% year-over-year decrease, indicating challenges the company faces in the current economic climate.
- Historical Performance Review: Over the past two years, RYAM has only beaten EPS estimates 25% of the time and revenue estimates 50% of the time, highlighting considerable volatility in its performance and the need for cautious investor assessment.
- Management Changes: Rayonier Advanced recently appointed Scott Sutton as CEO, a move that may influence the company's strategic direction and future performance outlook.
See More
- Stock Surge: Rayonier Advanced Materials (RYAM) saw a 42% increase in stock price after rejecting a buyout offer of $11 to $12 per share, indicating strong market confidence in the company's independent growth trajectory.
- Bid Details: American Industrial Partners, which holds a 5.07% stake in RYAM, made a cash offer in November, reflecting recognition of the company's value, but received a rejection letter in December, showcasing management's stance against the acquisition.
- Market Capitalization: With a market cap of approximately $500 million, Rayonier Advanced stands out in its industry, highlighting its relative size and potential growth opportunities that attract investor interest.
- Upcoming Earnings Report: The company is set to report its Q4 results next Wednesday, with the market eagerly anticipating its performance to further assess the financial health and future growth potential of the business.
See More
- Strong Dow Performance: The Dow Jones index gained over 200 points on Wednesday, rising 0.41% to close at 49,375.99, indicating positive market sentiment and increased investor confidence.
- NASDAQ and S&P 500 Rise: The NASDAQ surged 0.77% to 23,040.20, while the S&P 500 rose 0.55% to 6,928.15, reflecting strong performances in technology and other major sectors.
- Lowe's Earnings Beat Expectations: Lowe's reported Q4 earnings of $1.98 per share, exceeding analyst expectations of $1.94, with sales of $20.584 billion also surpassing the consensus estimate of $20.334 billion, although the company issued weaker future earnings guidance.
- Energy Stocks Decline: Energy stocks fell by 0.3% on Wednesday, contrasting with a 0.8% rise in information technology shares, indicating a divergence in market performance that could influence investor asset allocation strategies.
See More

- EPS Revision Grade Analysis: As the earnings season approaches, an analysis reveals that several mid to low cap material stocks have received an 'F' EPS revision grade, indicating significant downward pressure on future earnings expectations, which may lead to decreased investor confidence.
- List of Affected Companies: Companies such as American Battery Technology Company (ABAT), Algoma Steel Group Inc. (ASTL), and Eastman Chemical Company (EMN) have all received an 'F' grade, highlighting serious challenges in their earnings momentum.
- Market Impact Assessment: The poor EPS revision grades of these companies could adversely affect their stock performance, prompting investors to carefully assess associated risks, especially during the earnings season when market sensitivity to earnings is heightened.
- Industry Outlook: With the earnings season underway, the overall performance of the materials sector may be dragged down by these low-rated companies, leading investors to seek out better-performing firms within the industry for potential investment opportunities.
See More

- FDA Certification Impact: Altimmune Inc's Pemvidutide received FDA Breakthrough Therapy Designation, leading to a 23.6% surge in shares to $4.34 on Monday, indicating strong market confidence in its potential efficacy and possibly accelerating its path to market.
- Clinical Progress: GH Research PLC's GH001 lifted from FDA clinical hold saw shares rise 33.8% to $17.72, reflecting significant advancements in drug development that are expected to enhance its competitive position in the market.
- Executive Change: Rayonier Advanced Materials Inc appointed Scott M. Sutton as the new CEO, resulting in a 14.1% increase in shares to $6.68, suggesting that this leadership change could bring new strategic directions and growth opportunities for the company.
- Market Rebound: The overall market showed strong performance with the S&P 500 index rising, reflecting investor optimism about economic recovery, which may drive more capital inflows into the stock market.
See More
- Leadership Change: Rayonier Advanced Materials announced the appointment of Scott Sutton as CEO and President effective January 5, succeeding DeLyle Bloomquist, whose planned retirement ensures leadership continuity and ongoing strategic initiatives.
- Experienced Successor: Sutton brings over 30 years of industry experience, having previously served as CEO and President of Olin Corp, and his extensive management background is expected to provide new growth opportunities for the company.
- Market Reaction: Following the leadership announcement, Rayonier Advanced Materials' stock closed down 0.51% at $5.86 on the New York Stock Exchange, indicating market caution regarding the company's future direction.
- Strategic Support: Bloomquist will remain as an advisor to support the leadership transition and ongoing strategic initiatives, aiming to ensure stability and continued growth during this period of change.
See More






